Picture of CellaVision AB logo

CEVI — CellaVision AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Momentum

Relative Strength (%)
1m+6.35%
3m+11.86%
6m+22.97%
1yr-0.24%
Volume Change (%)
10d/3m+91.17%
Price vs... (%)
52w High-31.48%
50d MA+4.7%
200d MA+0.85%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)48.09
PEG Ratio (f)2.64
EPS Growth (f)22.23%
Dividend Yield (f)0.77%
Valuation (ttm)IndustryMarket
Price to Book Value14.07
Price to Tang. Book37.57
Price to Free Cashflow69.29
Price to Sales13.85
EV to EBITDA39.28

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital24%
Return on Equity25.81%
Operating Margin29.32%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueSEKm309.31364.81461.77471.44565.5566276116.37%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+16.59+27.2+11.82-6.88+35.72+22.93+21.67n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for CEVI

Factors that could move the Cellavision Ab share price background image

Factors that could move the Cellavision Ab share price

Covid-19 has shaken world markets. One question likely to be on the minds of a lot of investors right now is how economic uncertainty caused by the pandemic will continue to affect mid-cap shares, such as the share price of Cellavision...

Four signs of a competitive moat at Cellavision Ab (STO:CEVI) background image

Four signs of a competitive moat at Cellavision Ab (STO:CEVI)

Given that widespread uncertainty in the stock market is likely to endure for the rest of 2020 and beyond, it pays to know that you're investing in high-quality stocks, rather than speculative ones. This means safe, profitable companie...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of CellaVision AB EPS forecast chart

Profile Summary

CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

Directors

Last Annual
December 31st, 2021
Last Interim
March 31st, 2022
Incorporated
January 1st, 1970
Public Since
May 28th, 2007
No. of Shareholders
8,030
No. of Employees
213
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
se flag iconOMX Nordic Exchange Stockholm
Shares in Issue
23,851,547

CEVI Share Price Performance

Upcoming Events for CEVI

Q2 2022 CellaVision AB Earnings Release

Q3 2022 CellaVision AB Earnings Release

Similar to CEVI

Picture of Acarix AB logo

Acarix AB

se flag iconOMX Nordic Exchange Stockholm

Picture of AdderaCare AB logo

AdderaCare AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Aegirbio AB logo

Aegirbio AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Arcoma AB logo

Arcoma AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Arjo AB (publ) logo

Arjo AB (publ)

se flag iconOMX Nordic Exchange Stockholm

FAQ

Or unlock with your email

Or unlock with your email